Your browser doesn't support javascript.
loading
Advancements in Cortisol Detection: From Conventional Methods to Next-Generation Technologies for Enhanced Hormone Monitoring.
Vignesh, Visesh; Castro-Dominguez, Bernardo; James, Tony D; Gamble-Turner, Julie M; Lightman, Stafford; Reis, Nuno M.
Afiliação
  • Vignesh V; Department of Chemical Engineering and Centre for Bioengineering and Biomedical Technologies (CBio) University of Bath, BA2 7AY Bath, U.K.
  • Castro-Dominguez B; Department of Chemical and Engineering and Digital Manufacturing and Design University of Bath, BA2 7AY Bath, U.K.
  • James TD; Department of Chemistry, University of Bath, BA2 7AY Bath, U.K.
  • Gamble-Turner JM; Department of Psychology, Bournemouth University, BH12 5BB Bournemouth, U.K.
  • Lightman S; Translational Health Sciences, Bristol Medical School, University of Bristol, BS1 3NY Bristol, U.K.
  • Reis NM; Department of Chemical Engineering and Centre for Bioengineering and Biomedical Technologies (CBio) University of Bath, BA2 7AY Bath, U.K.
ACS Sens ; 9(4): 1666-1681, 2024 04 26.
Article em En | MEDLINE | ID: mdl-38551608
ABSTRACT
The hormone cortisol, released as the end-product of the hypothalamic-pituitary-adrenal (HPA) axis, has a well-characterized circadian rhythm that enables an allostatic response to external stressors. When the pattern of secretion is disrupted, cortisol levels are chronically elevated, contributing to diseases such as heart attacks, strokes, mental health disorders, and diabetes. The diagnosis of chronic stress and stress related disorders depends upon accurate measurement of cortisol levels; currently, it is quantified using mass spectroscopy or immunoassay, in specialized laboratories with trained personnel. However, these methods are time-consuming, expensive and are unable to capture the dynamic biorhythm of the hormone. This critical review traces the path of cortisol detection from traditional laboratory-based methods to decentralised cortisol monitoring biosensors. A complete picture of cortisol biology and pathophysiology is provided, and the importance of precision medicine style monitoring of cortisol is highlighted. Antibody-based immunoassays still dominate the pipeline of development of point-of-care biosensors; new capture molecules such as aptamers and molecularly imprinted polymers (MIPs) combined with technologies such as microfluidics, wearable electronics, and quantum dots offer improvements to limit of detection (LoD), specificity, and a shift toward rapid or continuous measurements. While a variety of different sensors and devices have been proposed, there still exists a need to produce quantitative tests for cortisol ─ using either rapid or continuous monitoring devices that can enable a personalized medicine approach to stress management. This can be addressed by synergistic combinations of technologies that can leverage low sample volumes, relevant limit of detection and rapid testing time, to better account for cortisol's shifting biorhythm. Trends in cortisol diagnostics toward rapid and continuous monitoring of hormones are highlighted, along with insights into choice of sample matrix.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hidrocortisona / Técnicas Biossensoriais Limite: Humans Idioma: En Revista: ACS Sens Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hidrocortisona / Técnicas Biossensoriais Limite: Humans Idioma: En Revista: ACS Sens Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido